Drugs and Cosmetics for Aging Boomers: A Surging MarketBCC ResearchMarch 1, 2002 175 Pages - SKU: WA763975 |
Countries covered: United States
|
Additional Information
STUDY GOAL AND OBJECTIVES
This study provides readers with an intensive examination of the growing market for drugs and cosmetics for aging boomers.
Not only does the report focus on the demographics and behavior patterns of the baby boomer generation but it also examines the group's significance as a major market segment within the United States drug and cosmetics industries. From this analysis, BCC provides estimates for current and future trends in market size, market participants, product lines and consumer attitudes.
REASONS FOR DOING THIS STUDY
Dramatic changes are taking place as "baby boomers" approach "old age." Many boomers are now over 50 and if one expands the definition to include the "war-baby" cohort then many are retired and about to receive Social Security. This generation has not mimicked preceding generations but has been one of trendsetters. Its members have a high participation rate in sports activities and are very exercise oriented. Consequently, in addition to experiencing the problems associated with aging, they will experience many sports-related problems.
Also, the concept of "looking one's age" does not appeal to a large number of members of this demographic, both male and female, and their reliance on cosmetic products already has been demonstrated. It is BCC's goal to fully identify and examine these trends and to forecast future market changes through 2006.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study defines the major markets driven by "baby boomers" and provides detailed information on:
This study will prove particularly beneficial to pharmaceutical and cosmetics industry participants who hold marketing, management and technical development positions. It also will benefit readers who are suppliers to these industries as well as investors, venture capitalists, and those interested in demographic trends within these industries.
SCOPE AND FORMAT
Included in this study are all products classified as drugs and cosmetics. These include products sold over-the-counter or by prescription. Also included are vitamins and herbal remedies, although these are not considered drugs.
These markets are defined in light of current and potential products, market segments, governmental and regulatory agencies, major companies competing in this market, relative market shares and impact of the worldwide market status.
METHODOLOGY AND INFORMATION SOURCES
The primary data collection method for this report focuses on interviews with industry and trade personnel, company sources, annual reports, government agency personnel, industry observers, scientists and industry professional organizations, as well as a survey of the retail markets. In addition to these primary data sources, secondary data research techniques included a literature search of BCC's extensive library, as well as medical and business libraries.
All data were analyzed by BCC personnel to determine specific findings and to make forecasts. Once these forecasts were obtained, they were validated by consultation with industry experts. Consequently, all estimates provided in this report represent a consensus opinion of BCC personnel, industry participants and industry observers. Growth forecasts are made in constant 2001 dollars based on the U.S. manufacturers' (wholesale) price level unless otherwise noted.
More United States General Pharmaceuticals Reports
Wholesale Sector by
First Research, Inc.
Brief Excerpt from Industry Overview Chapter: The wholesale distribution industry in the US includes about 300,000 companies with combined annual sales of about $5 trillion. Large ...
Pharmaceuticals in the United States by
MarketLine
Introduction Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). ...
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on North America by
BCC Research
REPORT HIGHLIGHTS
The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion ...
Freedonia Focus on Excipients by
Freedonia Focus
This report discusses demand for pharmaceutical excipients in the US for the years 2005 and 2010, with forecasts for 2015. Topics covered include market ...
Pharmaceuticals Logistics Spending in the US to 2014 by
Datamonitor
Introduction Pharmaceuticals Logistics Spending in the US to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>